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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYHematopoietic stem and progenitor cells (HSPCs) can self-renew and create committed progenitors, a process supposed to involve asym-
metric cell divisions (ACDs). Previously, we had linked the kinetics of CD133 expressionwith ACDs but failed to detect asymmetric segre-
gation of classical CD133 epitopes on fixed, mitotic HSPCs. Now, by using a novel anti-CD133 antibody (HC7), we confirmed the occur-
rence of asymmetric CD133 segregation on paraformaldehyde-fixed and living HSPCs. After showing that HC7 binding does not
recognizably affect biological features of humanHSPCs, we studied ACDs in different HSPC subtypes and determined the developmental
potential of arising daughter cells at the single-cell level. Approximately 70% of the HSPCs of the multipotent progenitor (MPP) fraction
studied performed ACDs, and about 25% generated lymphoid-primedmultipotent progenitor (LMPP) as wells as erythromyeloid progen-
itor (EMP) daughter cells. SinceMPPs hardly created daughter cells maintainingMPP characteristics, our data suggest that under conven-
tional culture conditions, ACDs are lineage instructive rather than self-renewing.INTRODUCTION
Hematopoietic stem cells (HSCs) are defined as clono-
genic cells that are able to self-renew and generate he-
matopoietic progenitor cells (HPCs) of all hematopoietic
lineages. Triggered by the discovery of HSC niches (Calvi
et al., 2003; Schofield, 1978; Zhang et al., 2003), the un-
derstanding of the mechanisms and molecules involved
in cell-fate decisions of HSCs has increased considerably
(Le´vesque et al., 2010; Lymperi et al., 2010). Recently,
experimental evidence has been provided that HSCs
and distinct HPCs occupy different cellular niches: while
lymphoid progenitors inhabit endosteal niches, murine
HSCs reside in perivascular niches that specifically
depend on mesenchymal stromal cells (MSCs) and endo-
thelial cells (Ding and Morrison, 2013; Greenbaum et al.,
2013). In addition to extrinsic factors provided by the
environments of the different hematopoietic niches, he-
matopoietic stem and progenitor cells (HSPCs) contain
the capability to divide asymmetrically, demonstrating
that intrinsically controlled programs also participate in
cell-fate specification processes (Giebel, 2008; Go¨rgens
and Giebel, 2010).
Evidence for the occurrence of asymmetric cell divisions
(ACDs) during human early hematopoiesis was initially
provided by the observation that 30% of dividing
CD34+ or CD34+CD38low/ cells created daughter cells
that followed different proliferation kinetics and adopted1058 Stem Cell Reports j Vol. 3 j 1058–1072 j December 9, 2014 j ª2014 Thdifferent cell fates (Brummendorf et al., 1998; Huang
et al., 1999; Punzel et al., 2002). At a similar proportion,
dividing CD133+CD34+ HSPCs were found to create
CD133lowCD34+ cells (Beckmann et al., 2007). By studying
the subcellular distribution of cell-surface antigens
that are differentially expressed on CD133+CD34+ and
CD133lowCD34+ cells, we previously identified four cell-
surface antigens that segregate asymmetrically in 20%–
30% of dividing HSPCs and confirmed the hypothesis
that human HSPCs can divide asymmetrically (Beckmann
et al., 2007). Recently, we comprehensively compared the
developmental potential of human umbilical cord blood
(UCB)-derived CD34+ cells that expressed either high
CD133 (CD133+) or low/no CD133 (CD133) levels on
their cell surface. We demonstrated that CD133+CD34+
HSPCs can be subdivided by means of their CD45RA,
CD38, and CD10 expression into different cell fractions,
being enriched formultipotent progenitors (MPPs; CD133+
CD34+CD38CD45RACD10), lymphoid-primed multi-
potent progenitors (LMPPs; CD133+CD34+CD38CD45RA+
CD10), multilymphoid progenitors (MLPs; CD133+
CD34+CD38CD45RA+CD10+), or granulocyte-macro-
phage progenitors (GMPs; CD133+CD34+CD38+CD45RA+
CD10). The vast majority of CD133CD34+ progenitors
were found to belong to the erythromyeloid lineage
whose common progenitors were determined to be er-
ythromyeloid progenitors (EMPs; CD133CD34+ CD38+
CD45RACD10) (Go¨rgens et al., 2013b).e Authors
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to each other, it was found that GMPs are able to create
neutrophils but unexpectedly lack the potential to form
eosinophils and basophils. Furthermore, and against the
prevailing assumption, the GMPs were found to be de-
rivatives of the same branch of hematopoiesis as the
lymphocytes, pointing toward altered lineage relation-
ships in human hematopoiesis (Go¨rgens et al., 2013b).
Accordingly, we recently proposed a revised model of
human hematopoiesis (Go¨rgens et al., 2013a, 2013b).
Another outcome of this study was the observation
that under the conditions used, MPPs cannot self-renew
in vitro; following their first in vitro cell division, they
apparently create CD133-positive LMPPs and CD133-
negative EMPs, maybe by means of ACD (Go¨rgens
et al., 2013a, 2013b). Enforcing assumed roles of ACDs
in this lineage-separation process, asymmetric segrega-
tion of CD133 molecules was observed in a proportion
of dividing CD34+ cells at the intracellular level (Fonseca
et al., 2008). In contrast, and independent of its intracel-
lular distribution, the extracellular component of CD133
appeared to be symmetrically distributed on all dividing
CD34+ cells (Beckmann et al., 2007; Fonseca et al.,
2008).
In addition to the cell-fate analyses and ACD studies, we
compared the distribution of CD133 at the subcellular
level on freshly isolated and cultured HSPCs. Upon culti-
vation, HSPCs adopt a polarized morphology, forming a
leading edge at the front and a leukocyte-specific structure,
the uropod, at the rear (Giebel et al., 2004; Rajendran
et al., 2009). While CD133 showed a rather random
appearance on freshly isolated HSPCs, it redistributes to
the uropod tips in cultured HSPCs (Giebel et al., 2004;
Go¨rgens et al., 2012). In our studies, we learned that the
CD133 epitopes that are recognized by commonly used
anti-CD133 antibodies (AC133 and AC141) are sensitive
to paraformaldehyde fixation (Giebel et al., 2004). Both
of these antibodies have been reported to recognize
spatially distinct, glycosylation-dependent residues on
the extracellular CD133 loops (Bidlingmaier et al., 2008;
Miraglia et al., 1997). Recently, a novel monoclonal anti-
CD133 antibody, the HC7 antibody, has been described,
which specifically recognizes glycosylation-independent
protein residues of both extracellular loops of CD133
(Swaminathan et al., 2010). This antibody had been
successfully used in a variety of applications including
western blot, immunofluorescence, flow cytometry, and
immunohistochemistry using cancer cell lines (Swamina-
than et al., 2010).
To test for the usefulness of the HC7 antibody in hemato-
poietic stem cell research, we comprehensively compared
the presence and subcellular distribution of HC7 and
glycosylation-dependent CD133 epitopes on freshly iso-Stem Cell Replated and cultured UCB-derived CD133+CD34+ HSPCs.
Furthermore, we tested whether binding of the HC7 or
the AC133 antibody exerts any functional impact on the
biology of human HSPCs, including their potential to
home and engraft into immunodeficient nonobese dia-
betic/severe combined immunodeficiency (NOD/SCID)
mice. After showing that neither AC133 nor HC7 anti-
bodies recognizably alter biological features of human
CD133+CD34+ cells and that both antibodies allow
detection of living, asymmetrically dividing HSPCs, we
compared the ACD rates in MPP-, LMPP-, and GMP-en-
riched fractions of HC7-stained cells and analyzed MPP
daughter cells at a single-cell level, both phenotypically
and functionally.RESULTS
Subcellular Distribution of HC7 and AC133 Epitopes
on Polarized and Mitotic Human HSPCs
Recently, a novel anti-CD133 antibody has been described
whose epitopes, unlike those of classical AC133 and AC141
anti-CD133 antibodies, were claimed to be insensitive to
fixation (Swaminathan et al., 2010). Because of our interest
in analyzing the subcellular distribution of CD133 on
polarized and mitotic HSPCs, we decided to test for the us-
ability of the HC7 antibody in human hematopoietic stem
cell research.
At first, to analyze the specificity of the HC7 antibody, we
compared the ability of the HC7 antibody and that of the
commercially available AC133, AC141, and W6B3C1
anti-CD133 antibodies to bind to the ectopically expressed
CD133 splice variants. To this end, we transduced cells of
the human CD133 erythroleukemic cell line K562 with
lentiviral vectors, encoding the human CD133 splice
variant s1 or s2. Flow cytometric analyses revealed that
none of the antibodies bound to nonmanipulated or
enhanced GFP (EGFP)-expressing control K562 cells. In
contrast, all antibodies bound to CD133-transduced K562
cells, regardless whether they expressed the s1 or the
s2 EGFP variants of CD133 (Figure S1 available online).
Noteworthy, all antibodies showed comparable staining
intensities, which expectedly increased with higher EGFP
intensities. Since we did not recognize differences in the
staining intensity among the commercially available anti-
bodies, we decided to focus on the comparison of HC7
and AC133 and did not include AC141 and W6B3C1 in
our further analyses.
Next, we studied the subcellular distribution of HC7
and AC133 antigens on polarized as well as mitotic
human HSPCs that were fixed in paraformaldehyde
before staining. According to our previous finding that
upon cultivation CD133+CD34+ cells adopt a migrationorts j Vol. 3 j 1058–1072 j December 9, 2014 j ª2014 The Authors 1059
Figure 1. Subcellular Distribution Ana-
lyses of HC7, but Not AC133, Epitopes
Allow Detection of Asymmetrically
Dividing Cells within Paraformaldehyde-
Fixed HSPC Samples
(A) Subcellular localization of AC133 and
HC7 epitopes on 50–60 hr cultured,
morphologically polarized CD133+CD34+
cells.
(B) Epitope localization on mitotic cells
with symmetric (upper row) or asymmetric
distribution (lower row) of the HC7
epitopes.
Scale bars, 10 mm. See also Figure S1 and
Table S2 for a summary of observed fre-
quencies of asymmetric versus symmetric
HC7 epitope distributions.
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Asymmetric Cell Divisions in Human HSPCsphenotype and redistribute CD133 to the tip of the uro-
pod (Giebel et al., 2004), we performed these analyses
with CD34+ cells that had been cultured for 50–60 hr
in the presence of early-acting cytokines. Regardless of
whether we counterstained the HC7 or AC133 with
Cy3- or Alexa 488-conjugated secondary antibodies,
respectively, double-stained CD34+ cells revealed a high
overlap among the HC7 and AC133 antigens, with the
highest concentration of both antigens at the tips of the
uropods (Figure 1A). Confirming our previous data, asym-
metric distributions of AC133 epitopes were not observed
in any of the dividing HSPCs studied. As described before,
the AC133 epitopes were found to be concentrated in the
region of the cleavage furrow or in later mitotic stages on
midbodies, respectively (Beckmann et al., 2007). Remark-
ably, on mitotic HSPCs, the HC7 epitopes revealed a
different distribution than the AC133 epitopes. On the
vast majority of the mitotic HSPCs studied, HC7 epitopes
covered areas of the cell surface of arising daughter cells
that were negative for the AC133 staining. Strikingly, in
all of five independent experiments, mitotic HSPCs were
identified (27.5% ± 4.8%) displaying HC7 expression
mainly in one of the arising daughter cells and thus
revealing asymmetric HC7 epitope distributions (Fig-
ure 1B; Table S2). These findings implied that on mitotic
HSPCs, extracellular HC7 epitopes either segregate differ-
ently than AC133 epitopes or the fixation conditions used1060 Stem Cell Reports j Vol. 3 j 1058–1072 j December 9, 2014 j ª2014 Thcause artifacts, either affecting the distribution of AC133
or of HC7 epitopes.
HC7 and AC133 Label Identical Subpopulations of
Human HSPCs
To exclude fixation artifacts, we compared the expres-
sion of AC133 and HC7 antigens on both freshly isolated
human CD34+ cells and CD34+ cells that were cultured
for 50–60 hr by flow cytometry. To discriminate distinct
subpopulations, we costained the CD34+-enriched
cells with anti-CD34, anti-CD38, and anti-CD45RA anti-
bodies as well as with phycoerythrin (PE)-conjugated
HC7 and allophycocyanin (APC)-conjugated AC133
antibodies.
The CD34+ cells showed slightly higher contrasts with
the conjugated HC7-PE antibody than with the AC133-
APC antibody. However, the general pattern and the per-
centages of all identifiable subpopulations are comparable
to each other, and the direct comparison plots show that
the more AC133 epitopes were expressed on given cells,
the higher was their HC7 intensity, independently of
whether freshly isolated or cultured CD34+ cells were
analyzed (Figure 2A). To this end, we could not detect
any differences in HC7 and AC133 epitope expression.
Thus, the flow cytometric analyses did not support the
notion that HC7 and AC133 epitopes might be expressed
independently from each other.e Authors
Figure 2. AC133 and HC7 Antibodies
Allow Tracking of ACDs in Living HSPCs
over Time
(A) AC133 and HC7 epitope expression on
either freshly isolated CD34+ cells (left
panel) or CD34+ cells that had been cultured
for 50–60 hr in the presence of early-acting
cytokines before (right panel). Cells were
stained simultaneously with anti-AC133,
anti-HC7, anti-CD34, anti-CD38, and anti-
CD45RA antibodies. To analyze the expres-
sion of AC133 and HC7 epitopes on different
HSPC subpopulations, obtained expression
levels were plotted to those of CD34, CD38,
and CD45RA and compared to each other.
(B) Time-lapse images (extracted from
Movie S1) showing asymmetric segregation
of HC7 epitopes of a mitotic CD133+CD34+
cell.
(C) Time-lapse images showing asymmetric
segregation of AC133 epitopes of a mitotic
CD133+CD34+ cell. Scale bars, 10 mm.
See also Figure S2 and Movie S1.
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Asymmetrically Dividing Human HSPCs
To test for the subcellular distribution of HC7 and AC133
epitopes on living HSPCs, we performed live-cell analyses
of CD133+CD34+ cells. To this end, we stained cultured
CD34+ cells with PE-conjugated HC7 or PE-conjugated
AC133 antibodies and reseeded them. Stained cells wereStem Cell Reptracked for 5 hr by time-lapse microscopy, taking photos
every 90 s. Related to the subcellular distribution on fixed
HSPCs, both epitope types were found to be highly en-
riched at uropod tips of polarized cells (Figure S2). To
analyze mitotic cells, 105 HC7- and 96 AC133-stained
HSPCs were tracked over time. Similar to the fixed
and HC7-stained mitotic HSPCs, 30.5% of the living,orts j Vol. 3 j 1058–1072 j December 9, 2014 j ª2014 The Authors 1061
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CD133 epitopes. Remarkably, and in contrast to the
fixed-cell analyses, a similar amount (29.1%) of AC133-
stained HSPCs showed asymmetric CD133 segregation as
well (Figures 2B and 2C; Movie S1). Thus, we conclude
that both HC7 and AC133 epitopes segregate asymmetri-
cally on a proportion of dividing HSPCs and that inmitotic
stages, fixation interferes with the detection of AC133
epitopes, but not with that of HC7 epitopes. Furthermore,
and provided binding of the HC7 or the AC133 antibody
does not affect any relevant biological process in HSPCs,
both anti-CD133 antibodies can be considered as valuable
tools for elaborated living-cell analyses within the early
human hematopoietic compartment.
Binding of HC7 or AC133 Antibodies Does Not Affect
the Cell Polarization, Migration, or Cell Adhesion
Capabilities of Human HSPCs
A number of antibodies directed against cell-surface mol-
ecules (e.g., the cell adhesion molecules VLA-4, VLA-5,
LFA-1, and CD44 or the phosphatase CD45) have been
found to interfere with biological features of human
HSPCs and leukemia-initiating cells, including their
homing and engraftment and/or differentiation capabil-
ities (Jin et al., 2006; Kollet et al., 2001; Shivtiel et al.,
2011; Zanjani et al., 1999). Since homing is a multistep
process that depends on cellular polarization, migration,
and cell adhesion (Go¨rgens et al., 2012; Lapidot et al.,
2005), we investigated whether binding of HC7 or
AC133 antibodies to HSPCs interferes with any of these
processes.
To this end, we assessed the potential impact of HC7
and AC133 binding on the ability of HSPCs to adopt
and maintain polarized morphologies. Following the
experimental strategy we had used previously to dissect
the polarization process of UCB-derived HSPCs (Go¨rgens
et al., 2012), we cultured freshly isolated CD34+ cells in
the presence or absence of HC7, AC133, or isotype control
antibodies and quantified the amount of polarized cells
after 16 hr (Figure 3A) and 50–60 hr (Figure 3B). In a sec-
ond setting, we added these antibodies to CD34+ cells that
had been cultured for 50–60 hr before and assessed the
amount of polarized cells 2 hr later (Figure 3C). In none
of the experimental settings did we detect any functional
impact of the HC7 or AC133 antibodies on the establish-
ment or maintenance of the cell polarization process of
HSPCs (Figures 3A–3C). Hence, neither HC7 nor AC133
antibodies affect the cellular polarization of human
HSPCs.
Next, the potential impact of HC7 and AC133 antibody
binding on the in vitro migration capabilities of CD34+
cells was studied. In a first approach, we quantified
HSPC migratory activity in transwell assays. In a second1062 Stem Cell Reports j Vol. 3 j 1058–1072 j December 9, 2014 j ª2014 Thapproach, the motility and velocity of individual HSPCs
were determined by time-lapse microscopy. For the trans-
well experiments, CD34+ cells that had been cultured for
50–60 hr were transferred onto 3-mm-pore-sized transwell
inserts, either nonlabeled or labeled with HC7, AC133, or
isotype control antibodies. After, 12–14 hr, transmigration
rates were recorded. We did not observe any difference in
the ratio of transmigrated CD34+ cells in any of the set-
tings (Figure 3D). For the quantification of the migratory
velocity, individual CD34+ cells that had been cultured for
50–60 hr in the presence or absence of the corresponding
antibodies were tracked by time-lapse imaging for 2 hr.
Again, we did not detect any significant difference be-
tween the individual samples (Figure 3E). Thus, binding
of HC7 and AC133 antibodies does not interfere with
the in vitro migratory capabilities of UCB-derived CD34+
cells.
Finally, we compared the adhesion capabilities of
non-anti-CD133-antibody-labeled and antibody-labeled
CD34+ cells. To this end, we transferred nonlabeled and
labeled PKH2-stained CD34+ cells that had been cultured
for 50–60 hr into a cell adhesion assay performed on
press-to-seal slides (Wagner et al., 2007). CD34+ cells were
allowed to attach to preseeded AFT024 stromal cells for
60 min. After sealing and turning the slide upside down,
and following incubation for 60 min, the percentage of
CD34+ cells that were still attached to the stromal cells
was quantified. Similar to the previous experiments, we
did not detect any difference among the antibody-treated
or control cells. Accordingly, the data indicate that binding
of HC7 or AC133 antibodies does not interfere with the cell
adhesion capabilities of CD34+ cells (Figure 3F).
The Binding of HC7 and AC133 Antibodies to Human
HSPCs Does Not Affect Their CFC Capabilities
Next, we compared whether the HC7 or AC133 antibodies
affect the development of HSPCs within the colony-form-
ing cell (CFC) assay. We labeled 50–60 hr cultured CD34+
cells with theHC7 or AC133 anti-CD133 antibodies. Subse-
quently, fluorescent cell sorting was performed to separate
CD133+CD34+ and CD133CD34+ cells (Figure 4A) and
transfer selected numbers of purified cells into the CFC
assay (Figure 4B). Regardless of whether the CD34+ cells
were labeled with the HC7 or AC133 antibody, the sorted
cell fractions formed comparable colony numbers in all
settings (Figure 4C). In good agreement with our previous
studies (Go¨rgens et al., 2013b), progenitors with colony-
forming unit granulocyte-macrophage (CFU-GM) poten-
tials were almost exclusively recovered within the
CD133+CD34+ cell fractions, while progenitors revealing
erythroid and colony-forming unit mixed (CFU-MIX) po-
tentials were highly enriched within the CD133CD34+
cell fractions (Figure 4D). Since no differences in thee Authors
Figure 3. Binding of Neither AC133 nor HC7 Antibodies Recognizably Affects Cell Biological Properties of CD133+CD34+ Cells
The impact of AC133 and HC7 antibody binding on cell biological properties of cultured CD133+CD34+ cells was analyzed in different
settings: on the establishment of morphological cell polarity (antibodies were added before cultivation) (A and B), on the maintenance of
morphological cell polarity (antibodies were added following cultivation) (C), on their in vitro migratory activity measured in the transwell
assay (D), on their in vitro motility measured by tracking their movements via time-lapse microscopy (E), and on their cell adhesion
capabilities measured as the frequency of cells that tightly adhered to AFT024 stromal cells (F). In all settings, nontreated (control) or
isotype-treated CD34+ cells (isotype) were used as controls. Pictures to the right of the bar graphs show images of cultured HSPCs at
specified time points (A–C), on the microporous membrane (3 mm pore size) of a transwell insert (D), a center-corrected plot of the
migration patterns of individually tracked HSPCs (E), and of PKH2-stained CD34+ cells that adhered to AFT024 stromal cells (F). n, number
of independent experiments; arrow bars are given as SD of the mean; scale bars, 10 mm.
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says of corresponding HC7- and AC133-labeled CD34+
cell fractions, we conclude that binding of these antibodies
does not affect the colony-formation potential of UCB-
derived HSPCs.Stem Cell RepHC7- and AC133-Stained HSPCs Reveal Comparable
Engraftment Potentials
With the example of CD38, it had been demonstrated
that antibody labeling might have profound inhibi-
tory effects on the engraftment of human HSPCs inorts j Vol. 3 j 1058–1072 j December 9, 2014 j ª2014 The Authors 1063
Figure 4. AC133- and HC7-Stained CD34+ Cells Reveal Comparable In Vitro and In Vivo Differentiation Potentials
(A) CD34+ cells cultured for 50–60 hr were stained with either AC133 or HC7 and anti-CD34 antibodies and flow cytometrically analyzed
before (presort) or after fluorescent cell sorting of CD133+CD34+ cells (postsort).
(B) Experimental strategy for in vitro and in vivo analysis of sorted cell fractions using either AC133 or HC7 antibodies.
(legend continued on next page)
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Asymmetric Cell Divisions in Human HSPCsNOD/SCID mice (Taussig et al., 2008). To test whether
binding of the HC7 antibody has any impact on the
capacity of human HSPCs to home and engraft into the
bone marrow of NOD/SCID mice, we compared multili-
neage engraftment potentials of HC7- and AC133-labeled
human HSPCs. According to our previous findings
that SCID-repopulating cells are exclusively contained
within the CD133+CD34+ subpopulations (Go¨rgens
et al., 2013b), we purified CD133+CD34+ cells from
UCB-derived CD34+ cells that had been cultured for 50–
60 hr and were labeled with either the HC7 or AC133
antibody (Figures 4A and 4B).
NOD/SCID mice were transplanted with 5 3 104 cells
of either sorted CD133+CD34+ cell population. After
8 weeks, human cell engraftment in the bone marrow
of transplanted mice was quantified using anti-human
CD45 antibodies (Figure 4E). We detected comparable
engraftment rates in mice transplanted with HC7-labeled
CD34+ cells and those with AC133-labeled CD34+ cells
(Figure 4F). Multilineage analyses of the bone marrow
and quantification of the number of human cells express-
ing lymphoid (CD19/20 and CD56) or erythromyeloid
(CD71, CD13, CD14, and CD15) antigens did not show
any quantitative differences between both experimental
groups (Figures 4G and 4H). Thus, our data did not reveal
any specific impact of the binding of HC7 or AC133 anti-
bodies on the transplantation outcomes. In summary, our
in vitro and in vivo data provide evidence that binding of
HC7 and AC133 antibodies to human HSPCs does not
alter any relevant biological features of labeled human
HSPCs.
The Vast Majority of HSPCs of the MPP, but Not LMPP
or GMP, Fraction Perform Asymmetric Cell Divisions
In Vitro
Previously, we analyzed the developmental capacity of
separated offspring of primitive human hematopoietic
cells at a single-cell level. We showed that more than 80%
of very primitive cells, those with myeloid-lymphoid initi-
ating cell (ML-IC) potential, gave rise to daughter cells
adopting different cell fates. In contrast, a higher propor-(C and D) Total CFC frequencies of AC133- and HC7-stained CD133+CD3
obtained colony subtypes (D).
(E and F) CD34+ cells cultured for 50–60 hr were purified by fluorescent
of 50,000 CD133+CD34+ cells were transplanted in four independent
engraftment was determined uponmeasuring the content of human CD
and plotted in comparison to each other (F).
(G) The content of hematopoietic subpopulations within the human C
detection of B cells (CD19/20), natural killer cells (CD56), erythroid c
and granulocytes (CD15).
(H) Obtained results were plotted in comparison to each other.
n, number of independent experiments; N, number of mice; arrow ba
Stem Cell Reption of committed progenitors created identically devel-
oping daughter cells (Giebel et al., 2006). The observation
that only 20%–30% of CD133+CD34+ cells showed asym-
metric segregation of CD53, CD62L, CD63, or CD71 (Beck-
mann et al., 2007) or of the CD133 epitopes (Table S2),
respectively, implies different ACD rates among different
HSPC subpopulations. To this end, we decided to deter-
mine the ACD rates of CD133+CD34+ cells belonging to
the MPP, LMPP, or GMP subpopulation (Figure 5A). Due
to the complexity of the envisioned experiments and
the fact that the HC7, but not AC133, antibody recognizes
asymmetrically segregating CD133 epitopes on fixed
HSPCs, we decided to perform the following experiments
with the HC7 antibody only.
To study ACD rates in MPPs, LMPPs, and EMPs, cells of
all fractions were purified by fluorescent cell sorting (Fig-
ure S3) and cultured for 50–60 hr before they were labeled
with anti-HC7-PE antibodies and reseeded for time-lapse
microscopy (Figure 5B). Labeled cells were tracked for
5 hr, taking photos every 90 s (Figures 5C and 5D). A total
of 67.1% ± 3.4% of the mitotic cells of the MPP fraction,
30.8% ± 1.1% of the LMPP fraction, and 15.2% ± 0.7%
of the GMP fraction revealed asymmetric segregation pat-
terns of HC7 epitopes. The remaining mitotic cells of the
analyzed cell fractions revealed rather symmetrical segre-
gation of HC7 epitopes (Figures 5E and 5F). Together, these
findings confirm the long-lasting hypothesis that more
primitive human hematopoietic cells display higher ACD
rates in vitro than committed progenitors (Giebel et al.,
2006).
Cells of the MPP Fraction Create LMPP- and EMP-like
Daughter Cells
The observation that most cells of the MPP fraction divide
asymmetrically, coupled to the finding that MPPs create
LMPPs and EMPs in bulk cultures (Go¨rgens et al., 2013a,
2013b), implies that ACDs control segregation of the lym-
phomyeloid and erythromyeloid lineages from MPPs by
creating a pair of daughter cells, one inheriting LMPP and
the other EMP potential (Figure 6A). To test this hypothe-
sis, we decided to perform single-cell analysis of individual4+ and CD133CD34+ cells (C) as well as the total frequencies of the
cell sorting according to the gating strategy shown in (A). Aliquots
experiments to a total of 23 NOD/SCID mice. The total human cell
45+ cells in the mice’s bonemarrow 8 weeks after transplantation (E)
D45+ cell fractions was determined by using markers specific for the
ells (CD71), myeloid cells (CD13), monocytes/macrophages (CD14),
rs are given as SD of the mean.
orts j Vol. 3 j 1058–1072 j December 9, 2014 j ª2014 The Authors 1065
Figure 5. Most Mitotic HSPCs of the MPP-
Enriched, but Not LMPP- and GMP-En-
riched, Cell Fractions Reveal Asymmetric
Segregation of HC7 Epitopes
(A) Recently, we proposed a revised version
of the hematopoietic tree predicting
different lineage relationships (Go¨rgens
et al., 2013b). Accordingly, MPPs can be
enriched as CD133+CD34+CD45RACD38low
CD10CD7, LMPPs as CD133+CD34+CD45RA+
CD38lowCD10CD7+/, and GMPs as CD133+
CD34+CD45RA+CD38+CD10CD7 cells.
(B) Experimentally, MPP-, LMPP-, and GMP-
enriched fractions were sort purified from
freshly isolated CD34+ cells (Figure S3) and
cultured for 50–60 hr in the presence of
early acting cytokines. After staining with
PE-conjugated HC7 antibodies, cells were
tracked via time-lapse microscopy (90 s time
intervals) and discriminated regarding their
HC7 epitope segregation behavior, either as
asymmetrically or symmetrically dividing
cells.
(C and D) Example of an asymmetrically
dividing cell of the MPP fraction (C) and a
symmetrically dividing cell of the GMP frac-
tion (D).
(E) Comparison of the ACD rates within the
MPP-, LMPP-, and GMP-enriched fractions
obtained in two independent experiments.
(F) The embedded table summarizes the data.
n, number of independent experiments;
arrow bars are given as SD of the mean. See
also Figure S3.
Stem Cell Reports
Asymmetric Cell Divisions in Human HSPCscells of the MPP fraction, i.e., of CD133+CD34+CD45RA
CD38low/ cells (Figure 6A). For setting up and validating
the experimental strategy, we studied the population ki-
netics of bulk MPP cultures first. To this end, two indepen-
dent experiments were performed with five repetitions
each. A total of 100 or 10 cells of theMPP fractions were pu-
rified by fluorescent cell sorting and deposited into wells of
a 96-well plate, respectively, and cultured for 6 days. After
confirming the occurrence of cell proliferation in all given
wells by light microscopy, the resulting progeny fractions
were analyzed by flow cytometry. In good agreement
with our previous data (Go¨rgens et al., 2013b), cells reflect-
ing the LMPP (CD133+CD34+CD45RA+) and EMP pheno-
type (CD133CD34+CD45RA) were found in all progeny
fractions (Figure 6B), implying that reduction of the cell
numbers does not affect the appearance of LMPP- and
EMP-like daughter cells. Next, in two independent experi-
ments, a total of 339 individual cells of the MPP fraction
were deposited into individual wells of a 96-well plate,
raised for 6 days, and analyzed by flow cytometry and,1066 Stem Cell Reports j Vol. 3 j 1058–1072 j December 9, 2014 j ª2014 Thin selected cases, in CFC assays (Figure 6C). Following culti-
vation, 292 of them performed at least one cell division,
creating up to 36 sibling cells (Figure 6D). A total of
95 randomly chosen wells with progeny fractions were
analyzed by flow cytometry. As summarized in Figure 6E
and exemplarily shown in Figure 6F, 23 (24.2%) fractions
contained cells revealing phenotypic characteristics
of both lymphomyeloid and erythromyeloid cells, 44
(46.3%) of lymphomyeloid cells, and 23 (24.2%) of eryth-
romyeloid cells. None of the cells of the remaining 5
(5.3%) fractions showed lymphomyeloid or erythromye-
loid characteristics.
To confirm the LMPP and EMP characteristics at a func-
tional level, offspring of 12 MPP candidates creating
lymphomyeloid and erythromyeloid siblings were sorted
in parallel to their analysis as single cells in CFC assays.
In 8 series out of 12, at least 1 lymphomyeloid and
1 erythromyeloid sibling formed a colony, either of the
CFU-GM or the CFU-MIX/CFU-erythrocyte type, respec-
tively (Figure S4). This demonstrates the existence of cellse Authors
Stem Cell Reports
Asymmetric Cell Divisions in Human HSPCswithin theMPP fraction that indeed contain the dual capa-
bility to create LMPP- and EMP-like cells in vitro.Cells of the MPP Fraction Create LMPP- and EMP-like
Daughter Cells by Means of ACDs
To test whether ACDs control separation of LMPP and EMP
lineages, we established amethod to track initial mitoses of
single cells of the MPP fraction, aiming to subsequently
separate arising daughter cells and to analyze their differ-
entiation potential in CFC assays (Figure 7A). In three in-
dependent experiments, a total of 288 single cells of the
MPP fractions were deposited into individual wells of a
96-well plate. After confirming the single-cell deposition
in 269 cases by light microscopy, cells were tracked for
16 hr (Figure 7A). In total, 100 mitoses were observed,
which could clearly be scored on the bases of HC7 anti-
body reactivity as either symmetric (37%) or asymmetric
(67%) (Figures 7B and S5; Movies S2 and S3). To separate
the daughter cells for subsequent cell-fate analyses, the
content of each of these wells were distributed in equal
proportions to three wells of a 96-well plate. Light micro-
scopic analyses confirmed that we managed to separate
the daughter cells of 39 initially deposited cells that in
terms of their HC7 epitope divided asymmetrically and
of 25 cells that apparently performed symmetric cell divi-
sions (SCDs; Table S3). Before CFC medium was added to
the wells, fluorescent microscopy allowed us to distinguish
wells containing CD133+ or CD133 siblings of ACDs,
respectively. As summarized in Figures 7D and 7E, in 29
of the cases resulting from ACDs and in 15 resulting
from SCDs, both daughter cells formed colonies. Accord-
ing to their appearance and objectivized by flow cytomet-
ric cell analyses (Figures 7C and S6), the prevailing colony
combination following ACD was with 18 cases in which
the CD133 sibling created a CFU-MIX colony and the
CD133+ sibling a CFU-GM colony. In contrast, with 13
cases, the prevailing combination of siblings that were
created by SCDs was one in which both siblings formed
CFU-GM colonies (Figures 7D and 7E; Table S4). Of note,
pairs of daughter cell with a CD133+ sibling creating a
CFU-MIX colony and a CD133 sibling a CFU-GM colony
were not observed in any of the experiments. These results
support the initial hypothesis that under the conditions
used, most MPPs divide asymmetrically to create LMPPs
and EMPs. Thus, within the MPP compartment, ACDs pro-
mote lineage instruction rather than self-renewal of multi-
potent HSPCs.DISCUSSION
By using the HC7 anti-CD133 antibody, we demonstrate
that almost all human HSPCs of the MPP fractionStem Cell Repwith confirmed lymphomyeloid and erythromyeloid
developmental potential perform ACDs in vitro to create
a lymphomyeloid CD34+CD133+CD45RA+ and a erythro-
myeloid CD34+CD133CD45RA daughter cell. In this
context, we first comprehensively tested for the usability
of the HC7 anti-CD133 antibody in human hematopoiet-
ic stem cell research. Side-by-side comparison of HC7
and the classical AC133 anti-CD133 antibody revealed
that on fixed mitotic HSPCs, HC7, in contrast to
AC133, allows detection of asymmetric CD133 distribu-
tion. Otherwise, no difference was detected regarding
either their epitope expression on human HSPC subsets
or their subcellular distribution on polarized or living
mitotic HSPCs. Therefore, we conclude that the different
appearance on fixed mitotic cells is an artifact caused by
paraformaldehyde fixation rather than a difference in the
HC7 and AC133 epitope distribution on HSPCs. Side-by-
side comparison of HC7 or AC133 binding to human
CD133+ HSPCs did not reveal a recognizable impact of
any of these antibodies on the cell biological features of
HSPCs, including their homing and repopulation capabil-
ities in NOD/SCID mice. Thus, we consider the binding
of both antibodies as functional neutral and conclude
that they provide valuable tools for live-cell analyses of
human CD133+ HSPCs.
Accordingly, we used the HC7 antibody to analyze the
ACD behavior of defined CD133+ HSPC subpopulations.
By tracking cells of the MPP fraction, almost 70% of
them were found to perform ACDs in vitro, independent
of whether they were tracked in bulk or single-cell cultures.
In contrast, only 30% or 15% of the cells of the LMPP or
GMP fractions performed ACDs, respectively. The high fre-
quency of ACDs within theMPP fraction is in line with our
previous observation that more than 80% of human
HSPCs with long-term myeloid (LTC-IC) and long-term
lymphoid potential (NK-IC), the ML-ICs, created daughter
cells realizing different cell fates: while one daughter cell
inherited the ML-IC capability, the other daughter cell ap-
peared to be more restricted (Giebel et al., 2006). The func-
tional data of the ML-IC assay were in good agreement
with the assumption that a hallmark of many somatic
stem cells is their ability to divide asymmetrically and
that dysregulation of ACDs can result in tumor formation,
as has been observed at the example larval neural stem
cells of Drosophila, the neuroblasts, which regularly
divide asymmetrically (Chang et al., 2012; Homem and
Knoblich, 2012), and in different mammalian tumors,
including oligodendrogliomas, mammary tumors, and
leukemia (Cicalese et al., 2009; Sugiarto et al., 2011; Wu
et al., 2007).
However, the observation of our functional and pheno-
typic single-cell analyses that most cells of the MPP
fractions divide asymmetrically to create LMPP- andorts j Vol. 3 j 1058–1072 j December 9, 2014 j ª2014 The Authors 1067
(legend on next page)
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Asymmetric Cell Divisions in Human HSPCsEMP-like cells, coupled to our previous observation that
MPPs are lost over time (Go¨rgens et al., 2013a, 2013b),
suggests that ACDs within the MPP fraction instruct line-
age diversification rather than control the self-renewal of
MPPs. Even though this prediction might appear contra-
dictory to our previous finding that HSPCs with ML-IC
potential always create at least one daughter cell inherit-
ing the ML-IC potential (Giebel et al., 2006), one has to
consider that LMPPs, like MPPs, also contain LTC-IC
and NK-IC potential (Go¨rgens et al., 2013b). Conse-
quently, a reduction of the MPP to the LMPP potential
cannot be resolved within the ML-IC assay in its current
form (Go¨rgens et al., 2013a). Thus, it remains an open
question whether human HSCs indeed contain the po-
tential to perform self-renewing ACDs, as proposed
before (Giebel et al., 2006), or if they exclusively control
lineage diversification.
A very well-studied process in which ACDs exclusively
control lineage diversification is the development of the
external sensory organs of Drosophila, the fly’s bristles.
Here, so-called sensory organ precursors repetitively divide
asymmetrically to form the four different cells of a given
external sensory organ (Gho et al., 1999). Unlike the situa-
tion in neuroblasts, mutations disturbing the asymmetry
of occurring cell divisions result not in the expansion of
the more primitive precursor cells but rather in cell-fate
switches of one of the daughter cells into the other (Gho
et al., 1999; Giebel and Wodarz, 2012).
Future studies might indicate whether ACDs within the
early human hematopoietic compartment are exclusively
related to those observed in the development of the
external sensory organs of Drosophila or whether at least
some HSPCs contain capabilities to perform neuroblast-
like, self-renewing ACDs.Figure 6. Cells of the MPP Fraction Create CD133+Lymphomyeloid
(A) Model proposing that MPPs (CD133+CD45RA) divide asymmetric
romyeloid (EMP; CD133low) daughter cells. The dot plot of purified cells
EMPs according to their expression levels of CD133 and CD45RA, and a
LMPP or EMP fraction, respectively.
(B) Experimental strategy to analyze progeny fractions received from
respectively. In two independent experiments, cells of the MPP fract
dividual wells of U-bottom 96-well plates, cultured for 6 days, and stai
cells were excluded from the analyses via DAPI staining; doublets were
gating. Scale bars, 50 mm.
(C) Experimental strategy to analyze progeny fractions received from
single cells into individual wells of a 96 well U-bottom plates, the plat
cultured for 6 days. Arising progeny were enumerated by bright-fie
described in (C). Scale bars represent 50 mm (4) and 200 mm (6).
(D) Distribution reflecting the enumeration of the progeny fraction s
(E) Distribution of the immunophenotypes of progeny fractions obta
(F) Representative examples of flow cytometric analyses of progeny fr
See also Figure S4.
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Cell Preparation and Cell Culture
Human UCB was obtained from donors after informed consent
according to the Declaration of Helsinki. The experimental usage
of UCB samples was approved by the local ethics commission.
Mononuclear cells (MNCs) were isolated from individual sources
by Ficoll (Biocoll Separating Solution, Biochrom AG) density
gradient centrifugation and highly enriched by magnetic cell sep-
aration as described previously (Giebel et al., 2004). If not used
immediately, cells were cultured in a humidified atmosphere
at 37C and 5% CO2 at densities of 0.5–1 3 10
5 cells/ml in
Iscove’s modified Dulbecco’s medium (Lonza) supplemented
with 20% fetal bovine serum (Biochrom), 100 U/ml penicillin,
and 100 U/ml streptomycin (Life Technologies) and with early-
acting cytokines (FLT3L, stem cell factor, and thrombopoietin,
each at 10 ng/ml final concentration [all PeproTech]).Flow Cytometric Analyses and Cell Sorting
Antibodies used for flow cytometric analysis and sorting are listed in
Table S1. For analyses of human graft compositions in mouse bone
marrow, sample cells were labeled with antibodies against CD13,
CD14, CD15, CD19, CD20, CD45, CD56, and CD71. Prior to the
labeling, Fc receptors were blocked using purified rat anti-mouse
CD16/CD32 monoclonal antibodies (Becton Dickinson [BD]).
For flow cytometric sorting, cultured CD34+ cells were labeled
with PE-conjugated AC133 and anti-CD34 antibodies or with
unconjugated HC7 antibody, counterstained with PE-conjugated
goat-anti-mouse secondary antibodies (Dianova), saturated with
mouse serum (Dianova), and subsequently stained with anti-
CD34 antibodies. For flow cytometric sorting of MPPs, LMPPs,
and GMPs, freshly isolated CD34+ cells were labeled with anti-
bodies against CD34, CD133, CD38, CD45RA, CD10, and CD7
as described before (Go¨rgens et al., 2013b).
Flow cytometric analyzes were performed on a FC500 flow cy-
tometer (Beckman Coulter), a LSRII (BD), and a FACSAria I (BD).as well as CD133low Erythromyeloid Daughter Cells
ally to create lymphomyeloid (LMPP; CD133+CD45RA+) and eryth-
of the MPP fraction indicates the classification of MPPs, LMPPs, and
rrows indicate proposed shifts of MPP daughter cells into either the
100 (upper row) or 10 (lower row) sorted cells of MPP fractions,
ion (Figure S3) were deposited by fluorescent cell sorting into in-
ned with anti-CD34, anti-CD133, and anti-CD45RA antibodies. Dead
discriminated by forward scatter area versus forward scatter height
individually sorted cells of MPP fractions. Following deposition of
ing efficiency was determined by bright-field microscopy. Cells were
ld microscopy and analyzed like the progeny of the bulk cultures
izes of 339 individually deposited cells of MPP fractions.
ined from 95 individually deposited cells of MPP fractions.
actions obtained from individually deposited cells of MPP fractions.
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Figure 7. Large Proportions of Asymmet-
rically Dividing Cells of the MPP Fraction
Create LMPP- and EMP-like Daughter Cells
(A) Experimental strategy for the separa-
tion and functional analysis of individual
daughter cells arising from cells of the MPP
fraction that were deposited as single,
HC7-stained cells and tracked for 16 hr via
time-lapse microscopy with 8–12 min time
intervals. The content of the wells was
analyzed by bright-field microscopy. Movies
of the wells containing two daughter cells
were analyzed for the occurrence of ACDs or
SCDs. Thewholemedia content ofwellswhose
daughter cells clearly arose from an ACD or
SCDweremixed and aspiratedwith a standard
pipette to separate the daughter cells and
distributed to three new wells. Successful
separations were confirmed by bright-field
microscopy. Siblings of ACD were discrimi-
nated as CD133+ and CD133 by fluorescence
microscopy. Wells with successfully sepa-
rated daughter cells were overlaid with CFC
assay medium and cultured for 14 days.
Arising CFC colonies were scored according to
their phenotype and analyzed by flow cy-
tometry (Figure S5) according to our previous
description (Go¨rgens et al., 2013b).
(B) Cumulative statistical overview of three
independent separation experiments. In
total, 39 or 25 cells of the MPP fraction
performed confirmed ACDs or SCDs, respec-
tively, and created daughter cells, both of
which formed colonies (details are given in
Table S3).
(C) Example of the prevailing colonies types
that were formed (either a CD133+ daughter
cell-derived CFU-GM colony or a CD133
daughter cell-derived CFU-MIX colony).
Scale bars, 200 mm.
(D and E) Combined output of the colony
assays of the siblings resulting from ACDs
(D) or SCDs (E), respectively (details are
given in Table S4).
See also Figures S5 and S6, Tables S3 and S4,
and Movies S2 and S3.
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Asymmetric Cell Divisions in Human HSPCsDead cells were excluded by propidium iodide or DAPI staining.
Isotype controls were used to set up gating strategies.
Cells were sort purified using a FACSAria I cell sorter (BD). The
sort purity was routinely assessed by recovery of sorted cells and
was >99.5%.Functional In Vitro Differentiation Assays
For colony-forming cell (CFC) assays, 200 sorted cells were seeded
into 1 ml MethoCult GF H4434 (STEMCELL Technologies);1070 Stem Cell Reports j Vol. 3 j 1058–1072 j December 9, 2014 j ª2014 Thindividual cells were immediately deposited into or for the
individual daughter cell analyses overlaid with 200 ml MethoCult
GF H4434, respectively. Hematopoietic colonies were scored after
12–14 days.
Statistics
Experimental results from independent experiments are reported
as SD. Significance analyses and data assembly were performed
with the paired, two-sided Student’s t test using Microsoft Excel
and GraphPad Prism.e Authors
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